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Letters to the Editortioned as well but there was neither
infiltration nor postoperative infusion. Af-
ter the operation we assessed pain control
by a visual analog scale at specific time
points (extubation and 12, 24, and 36
hours). We also recorded the assisted ven-
tilation time as well as the intravenous ad-
ministrations of analgesic drugs. Blood gas
analysis was performed at extubation and
at 6, 12, and 24 postoperative hours. Unlike
Dowling and associates’ findings,1 we
were unable to demonstrate any effective-
ness of this treatment, even though the drug
and its dosage were similar to those used in
their study. However, the protocol of these
authors consisted in a T1-T12 intercostal
nerve block, whereas we performed a local
soft-tissue infiltration. We therefore may
speculate that the efficacy of Dowling and
associates’ treatment was related more to
the intercostal nerve block than to the post-
operative continuous infusion, which was
common to both studies. An interesting
second step of their study would be the
comparison between the sole intercostal
nerve block and this procedure followed by
continuous anesthetic infusion. Regardless,
we may conclude that these attempts to
reduce postoperative pain are promising
and deserve future developments.
Giuseppe Rescigno, MD
Giannantonio Carnelos, MD
Cardiovascular Unit
Salus Hospital
Reggio Emilia, Italy
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Reply to the Editor:
We are responding to the letter of Racigno
and Carnelos. As they described, we per-
formed a double-blind randomized con-
trolled trial in which patients undergoing
elective bypass surgery received either bi-
lateral intercostal nerve block with ropiva-
caine or a saline placebo. At wound clo-
Tsure, two catheters with multiple side
openings were inserted percutaneously and
placed directly over the sternum. The same
agent (ropivacaine or saline solution) was
then administered as a continuous regional
infusion for 48 hours through an elasto-
meric pump. The main findings of our
study were that patients in the ropivacaine
group had improved postoperative pain
control and required less narcotic analge-
sia. Additionally, patients in the ropiva-
caine group had significantly lower pain
scores than did patients who received pla-
cebo, and length of stay was also decreased
in the ropivacaine group.
Racigno and Carnelos report doing a
similar randomized trial in which they were
unable to demonstrate any effectiveness of
this treatment. In their letter, however, it is
not clear how similar the therapeutic ap-
proaches truly were. We believe that a key
component in our study was the develop-
ment and clinical use of catheters with mul-
tiple side openings, which allow even dis-
tributions of the anesthetic agent
throughout the operative field. Racigno and
Carnelos reported using a small-diameter
catheter, but it is not clear whether this
catheter was effective in providing a true
regional anesthetic. They further suggested
that the difference in outcome may have
been related to the use in our study of
bilateral intercostal nerve block before per-
forming wound closure.
We believe this is unlikely to explain
the major differences seen between our two
groups for a number of reasons. First, it is
widely documented that intercostal nerve
blocks, even with long-acting anesthetic
agents, do not provide pain control beyond
6 to 8 hours. Second, we assessed pain
scores on the second postoperative day to
eliminate the effect of this and other con-
founding variables, such as residual anal-
gesia given at the time of operative therapy.
We were able to demonstrate marked de-
crease in narcotic use on the second post-
operative day, when clearly the patient
would not be receiving any benefit from the
intercostal nerve block.
In addition, since the submission of our
article a similar study has been performed
that has demonstrated the advantages of a
continuous local infusion for pain manage-
ment after median sternotomy.1 White and
colleagues1 performed a prospective, ran-
domized, placebo-controlled trial with the
same catheter system that was used in our
he Journal of Thoracic and Cardiovascularstudy. These investigators also showed a
significant reduction in pain scores, mor-
phine use, patient dissatisfaction, time to
ambulation, and duration of hospital stay.
In our opinion, the results of our study
and that of White and colleagues1 strongly
suggest that this approach will result in
improved patient comfort and satisfaction,
as well as decreased narcotic use after me-
dian sternotomy. As noted in both studies,
the use of the catheter does not require any
physician or nursing intervention after its
placement, and there has been no morbidity
associated with this approach. We consider
this approach an excellent first step to im-
proving the overall approach to pain man-
agement for our patients.
Robert D. Dowling, MD
Professor of Surgery
University of Louisville
Louisville, KY 40202
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Suggestion for functional model to
test effects of decellularization of rat
aortic valve allografts on leaflet
destruction and extracellular matrix
remodeling
To the Editor:
In their article “Decellularization of Rat
Aortic Valve Allografts Reduces Leaflet
Destruction and Extracellular Matrix Re-
modeling,” Grauss and colleagues1 ele-
gantly evaluated various methods of decel-
lularization of aortic valve conduits and
tested their structural integrity after im-
plantation in a rat model. Their findings
suggest that decellularization is possible
and may reduce the recipient’s immune
response to allogeneic tissue, as demon-
strated by preservation of the leaflets’
structural integrity in decellularized allo-
grafts relative to cellular allografts. Despite
the lack of immunologic data and the small
number of animals, they showed convinc-
ing histologic evidence reflecting these
findings.
However, one of the major limitations
affecting the generalizability of their find-
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Letters to the Editorings is that virtually all valved conduits
except for cellular syngrafts resulted in sig-
nificant sinus thrombus formation. This
limitation of the model used could have
been addressed in part by using a func-
tional model in which blood flow and leaf-
let mobility can be demonstrated.2 The sig-
nificance of sinus thrombosis is not
negligible, and it has been shown to be-
come a nidus for inflammatory cells, po-
tentially affecting neighboring cellular im-
mune responses and any conclusions made
from histologic examination.3,4
Jean-Francois Le´gare´, MD
David B. Ross, MD
Division of Cardiac Surgery
Dalhousie University
Halifax, Nova Scotia, Canada
Division of Pediatric Cardiac Surgery
University of Alberta
Edmonton, Alberta, Canada
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Reply to the Editor:
We thank Le´gare´ and Ross for their com-
ment on our article describing the in vivo
behavior of decellularized rat aortic valve
allografts. As they state in their letter, a
complication of the model we used is the
sinus thrombus formation observed in all
decellularized synergrafts and allografts, as
well as in the untreated allografts. They
speculate that this is due mainly to a lack of
leaflet mobility in a nonfunctional implan-
tation model.1
To overcome this difficulty Le´gare´ and
Ross suggest the use of a functional rat
implantation model in which the creation
156 The Journal of Thoracic and Cardiovaof native aortic valve insufficiency results
in a significant diastolic flow reversal in the
abdominal aorta, allowing leaflets to move
and function.2 Although we were aware of
the existence of this model, we decided not
to use it for our study. One reason is that
the creation of aortic insufficiency results
in progressive congestive heart failure from
volume overload, making the model un-
suitable for long-term follow-up studies. In
addition, a rather high mortality is seen in
the model (62.5% survival). We fully agree
about the importance of having functional
moving leaflets in the bloodstream in
studying aortic valve failure; however, we
look forward to new data that will encour-
age us to incorporate the model in our
future studies.
We respectfully disagree with the as-
sumption that a nonfunctional model is the
main reason for the sinus thrombus forma-
tion. Interestingly, in our study none of the
untreated (cellular) synergrafts displayed
thrombus formation. This is consistent with
earlier results in this model by Oei and
colleagues,1 who showed absence of
thrombus formation in all synergrafts and
even in some allografts. This indicates that
loss of cellular structures, resulting in an
absent blood-tissue barrier, from the
treated synergrafts and allografts and un-
treated allografts is an essential condition
in thrombus formation.
Our study suggests that decellulariza-
tion reduces the recipient’s immune re-
sponse, resulting in a preservation of the
extracellular matrix structure. We therefore
believe in the feasibility of acellular allo-
grafts as scaffolds for tissue-engineering
purposes and are performing seeding ex-
periments at the moment to determine the
best cell source.
Regarding the influence of thrombosis
on the inflammatory response,3 seeding of
acellular valves with autologous endothe-
lium will result in a new blood-tissue bar-
rier and is expected to protect against
thrombus formation. We therefore believe
that this model is suitable for further re-
search in tissue engineering of aortic
valves.
Robert W. Grauss, MSc
Marco C. Deruiter, PhD
Mark G. Hazekamp, MD, PhD
Department of Anatomy and Embryology
Department of Cardiothoracic Surgery
Leiden University Medical CenterLeiden, The Netherlands
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Which is the best surgical strategy
for “complete” treatment of ischemic
cardiomyopathy?
To the Editor:
We read with great interest the article pub-
lished in the Journal by Maxey and asso-
ciates1 concerning surgery for ischemic
cardiomyopathy. First of all, Maxey and
associates are to be commended for out-
standing results in a challenging cohort of
patients. The study included 14 patients
who underwent mitral valve repair (MVR)
associated with coronary artery bypass
grafting and left ventricular restoration
(LVR), but Maxey and associates1 did not
mention the sequence of the surgical pro-
cedures. In a previous article, they reported
performing coronary artery bypass grafting
first, then MVR, and finally LVR.2
Ischemic mitral regurgitation is a func-
tional disorder that is due mainly to
changes in the geometric relationships be-
tween structurally normal valve compo-
nents and a severely damaged ventricle. By
changing ventricular volume and geome-
try, LVR may unpredictably result in mitral
insufficiency that is absent before surgery3
or in an amelioration (sometimes disap-
pearance) of mitral regurgitation.4 It there-
fore seems more rational to address MVR
after completely rebuilding ventricular ge-
ometry. In addition, this strategy allows
evaluation of valve competence after LVR
and a check on leaflet apposition (in
Bolling and associates’ experience,5 in ad-
dition to the annuloplasty ring 54 of 100
patients required further mitral repairs).
Moreover, after LVR with narrower con-
figuration and papillary muscles realign-
ment, the mitral incompetence may disap-
pear, thus making mitral valve repair
unnecessary. We could speculate that in the
only patient who showed persistent mitral
